|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Muhicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia:results of WMCTG Trial 03-248显示文摘 | Treon SP Hunter ZR | 2007 | Clin Cancer Res2007，13，： | 1 |
| 2 | Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248 显示文摘 | Treon SP Hunter ZR Matous J | 2007 | Clin Cancer Res2007，13，11： | 1 |
| 3 | A new era for Waldenstriim macroglobulinemia: MYD88 L265P显示文摘 | Treon SP Hunter ZR | 2013 | Blood2013，121，22： | 1 |
| 4 | Long time outcomes to fludarabine and rituximabin Macroglobulinemia 显示文摘 | TREON SP BRANAGAN AR HUNTER ZR | 2009 | Blood2009，113，16： | 1 |
| 5 | CD5, CD10, and CD23 expression in Waldenstrom 's macroglobulinemia 显示文摘 | Hunter ZR Branagan AR Manning R | 2005 | Clin Lymphoma2005，5，4： | 1 |
| 6 | Characterization of familial Waldenstrom's macroglobulinemia显示文摘 | Treon SP Hunter ZR Aggarwai A | 2006 | Ann Oncol2006，17，3： | 1 |
| 7 | CD5, CD10, andCD23 expression in Waldenstrom's macroglobulinemia显示文摘 | Hunter ZR Branagan AR Manning R | 2005 | ClinLymphoma2005，5，4： | 1 |
| 8 | Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia:results of WMCTG Trial 03-248显示文摘 | Treon SP Hunter ZR Matous J | 2007 | Clin Cancer Res2007，13，： | 1 |
| 9 | Phase II study of alemtuzumab in lymphoplasmacytic lymphoma: results of WMCTG trial 02-079显示文摘 | Hunter ZR Boxer M Kahl B et ai | 2006 | J Clin Oncol2006，24，18： | 1 |
| 10 | CD5 , CDlo, and CD23 expression in Waldenstrtim's macroglobulinemia显示文摘 | Hunter ZR Branagan AR Manning R | 2005 | Clin Lymphoma2005，5，4： | 1 |
| 11 | MYD88 L265P in waldenstrom's macroglobulinemia,IgM Monoclonal gammopathy,and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific PCR显示文摘 | Xu L Hunter ZR Yang G | 2013 | {H}Blood2013，，11： | 1 |
| 12 | Characterization of familial Waldenstrom's macroglobu nem a 显示文摘 | Treon SP Hunter ZR Aggarwal A | 2006 | Ann Oncol2006，17，3： | 1 |
| 13 | Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia:results of WMCTG Trial 03-248显示文摘 | Treon SP Hunter ZR Malous J | 2007 | Clin Cancer Res2007，13，11： | 1 |
| 14 | Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenstrtim' s maeroglobulinemia 显示文摘 | Ioakimidis L Patterson C J Hunter ZR | 2009 | Clin Lymphoma Myeloma2009，9，1： | 1 |
| 15 | Characterization of familial Waldenstrom's macroglobulinemia 显示文摘 | Treon SP Hunter ZR Aggarwal A | 2006 | Ann Oncol2006，17，3： | 1 |
| 16 | Multicenter clinical trial of bortezomib in relapsed/refractoy Waldenstrom’s macroglobulinemia:rusults of WMCTG Trial 03-248显示文摘 | Treon SP Hunter ZR Matous J | 2007 | Clin Cancer Res2007，13，11： | 1 |
| 17 | Detection of MYD88 L265P in peripheral blood of patients with Waldenstrom's Macro- globulinemia and IgM monoclonal gammopathy of undeter- mined significance显示文摘 | Xu L Hunter ZR Yang G | 2014 | Leukemia2014，28，8： | 1 |
| 18 | Multicenter clinical trial of bortezomib in relapsed/refractoy Waldenstrom's macroglobulinemla:rusults of WMCTG Trial 03-248显示文摘 | Treon SP Hunter ZR Matous J | 2007 | Clin Cancer Res2007，13，11： | 1 |
| 19 | IgA and IgG hy-pogammaglobulinemia in Waldenstrom’s macroglobuline-mia显示文摘 | Hunter ZR Manning RJ Hanzis C | 2010 | Haematologica2010，95，47： | 1 |
| 20 | Waldenstrom macroglobulinemia显示文摘 | Treon SP Hunter ZR Castillo JJ | 2014 | Hematol Oncol Clin North Am2014，28，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员